It's about functionality," says Dr. Richard Luskin, CEO of the New England Organ Bank.
"Anyone with this disfigurement would argue they're not living, they're surviving," says Luskin.
"Face transplants remain unique and require very specific criteria such as hairlines and ethnic components," explains a UNOS spokesperson.
"A major component for a successful procedure is patient selection on both the recipient and donor," he adds.
The surgery is classed by some as life-changing, not life-saving, which raises questions as to whether this risk is justified.
"We need new therapies which will be less harmful," she says.
"If the (immune system) can recognize more cells as 'self' the patient will need less anti-rejection drugs," says Siemionow, whose experimental therapy is hoped to enter clinical trials in a few years and when it does, may make face transplants more acceptable to critics.
"There is no ethical issue," he concludes.